NEVVI Medicare utilization intelligence

← back

GUANCIAL, ELIZABETHMD NPI 1124155569 Clinician

Hematology-Oncology · SARASOTA, FL

Specialty Hematology-Oncology — from billed Medicare claims
Trained HARVARD MEDICAL SCHOOL — medical school, self-reported to CMS
In practice about 20 years since medical school (class of 2006, self-reported to CMS)
Location SARASOTA, FL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 54 codes billed · 223,449 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J9177 Injection, enfortumab vedotin-ejfv, 0.25 mg
J9299 Injection, nivolumab, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0185 Injection, aprepitant, 1 mg
Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
J1434 Injection, fosaprepitant (focinvez), 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9171 Injection, docetaxel, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J0897 Injection, denosumab, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1437 Injection, ferric derisomaltose, 10 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
J2405 Injection, ondansetron hydrochloride, per 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
J9045 Injection, carboplatin, 50 mg
96413 Administration of chemotherapy into vein, 1 hour or less
Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J1954 Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
81003 Automated urinalysis test
96361 Infusion into a vein for hydration, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96411 Administration of additional new drug or substance into vein using push technique
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96374 Injection of drug or substance into vein
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
85046 Red blood count automated, with additional calculations
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
96360 Infusion into a vein for hydration, 31-60 minutes
99496 Transitional care management services for problem of high complexity
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.